B. Riley Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,066
Closed -$203K 1062
2025
Q3
$203K Buy
+1,066
New +$189K 0.01% 889
2024
Q2
Sell
-2,022
Closed -$246K 1441
2024
Q1
$246K Buy
2,022
+333
+20% +$43.2K 0.01% 1153
2023
Q4
$233K Sell
1,689
-333
-16% -$43.8K 0.01% 1178
2023
Q3
$246K Sell
2,022
-546
-21% -$72.7K 0.01% 1153
2023
Q2
$361K Buy
2,568
+1,069
+71% +$147K 0.01% 1025
2023
Q1
$212K Sell
1,499
-70
-4% -$10K 0.01% 1265
2022
Q4
$245K Buy
+1,569
New +$225K 0.01% 1149
2022
Q3
Sell
-1,748
Closed -$233K 1469
2022
Q2
$233K Buy
1,748
+19
+1% +$2.59K 0.01% 974
2022
Q1
$237K Sell
1,729
-74
-4% -$10.3K 0.01% 1134
2021
Q4
$312K Sell
1,803
-3,059
-63% -$465K 0.01% 1046
2021
Q3
$707K Buy
4,862
+676
+16% +$98.9K 0.02% 641
2021
Q2
$553K Buy
4,186
+1,569
+60% +$205K 0.02% 721
2021
Q1
$336K Buy
+2,617
New +$322K 0.01% 937
2020
Q4
Sell
-4,493
Closed -$514K 1041
2020
Q3
$514K Buy
4,493
+1,751
+64% +$207K 0.03% 519
2020
Q2
$313K Buy
+2,742
New +$291K 0.02% 621
2017
Q4
Sell
-2,819
Closed -$265K 648
2017
Q3
$265K Buy
+2,819
New +$299K 0.04% 416
2015
Q1
Sell
-608
Closed -$41 892
2014
Q4
$41 Buy
+608
New +$38.4K ﹤0.01% 2190
2014
Q3
Sell
-476
Closed -$27.9K 921
2014
Q2
$27.9K Buy
+476
New +$27.9K 0.01% 1308

Other funds holding DGX

B. Riley Wealth Advisors's DGX Position: Q4 2025 in Review

B. Riley Wealth Advisors sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 1,066 shares — an estimated $203K sold.

B. Riley Wealth Advisors first reported a position in DGX in Q2 2014 and held it in 18 quarters. The position peaked at $707K in Q3 2021. 1,049 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • B. Riley Wealth Advisors reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 1,066 Quest Diagnostics shares in Q4 2025, an estimated $203K.
  • B. Riley Wealth Advisors first reported a position in Quest Diagnostics in Q2 2014 and held it in 18 quarters.
  • B. Riley Wealth Advisors's Quest Diagnostics position peaked at $707K in Q3 2021.
  • 1,049 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.